Company: ATRA
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-059322
Chunk: 10

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 10
---
 named executive officers                                                                                    |     | “For” votes from the holders of a majority of shares present in person, present by remote communication, if applicable, or represented by proxy and entitled to vote on the matter               |     | Against                                         |     | None                                            |
| 3              |     | Advisory approval of the frequency of future advisory votes on the compensation of our named executive officers                                          |     | The frequency (one, two, or three years) that receives the votes of a majority of the voting power of the shares present in person or represented by proxy and entitled to vote on the matter(1) |     | Against each of the proposed voting frequencies |     | None                                            |
| 4              |     | Ratification of the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 |     | “For” votes from the holders of a majority of shares present in person, present by remote communication, if applicable, or represented by proxy and entitled to vote on the matter               |     | Against                                         |     | Not applicable; brokers have discretion to vote |

(1) In the event that no frequency receives a majority of the votes, we will consider the frequency that receives the most votes cast to be the frequency approved, on an advisory basis, by our stockholders. What is the quorum requirement? A quorum of stockholders is necessary to hold a valid Annual Meeting. A quorum will be present if stockholders holding at least a majority of the outstanding shares entitled to vote are present at the Annual Meeting in person by remote communication or represented by proxy. On the Record Date, there were 5,961,323 shares outstanding and entitled to vote. Thus, the holders of 2,980,662 shares must be present in person by remote communication or represented by proxy at the Annual Meeting to have a quorum. Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your nominee) or if you vote in person by remote communication at the Annual Meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares present at the Annual Meeting in person by remote communication or represented by proxy may adjourn the Annual Meeting to another date. How can I find out the results of the voting at the Annual Meeting? Preliminary voting results will be announced at the